Risk of Congenital Anomalies with Dolutegravir-Based Anti-retroviral Regimens: A Systematic Review and Meta-analysis.

Shuvasree PayraDivya HarshaKeshav KumarPramod Kumar Manjhi Shruti Singh Rajesh Kumar Sunil Kumar Singh Alok Kumar Vikas Maharshi

Published in: Clinical drug investigation (2024)

The risk of congenital anomalies was not significantly different between dolutegravir-based regimens and non-dolutegravir-based-regimens in newborns exposed during their antenatal period.

Keyphrases

hiv infected patients
antiretroviral therapy
pregnant women
preterm birth
low birth weight
cord blood